Korea rare disease co-payment cut to 7% from December 2026
Korea's health insurance co-payment for rare and severe intractable diseases is set to fall from 10% to 7% for care received from December 1, 2026.
· 6 min read
Read in other languages한국어Español简体中文繁體中文日本語
Key takeaways (as of November 12, 2026)
- The Ministry of Health and Welfare issued the draft decree on November 4, 2026, and expects average annual out-of-pocket costs for about 1.36 million registered patients to fall from about KRW 750,000 to about KRW 530,000.
- Public comments on the draft are accepted until November 16, 2026, while non-covered treatment costs and the 50% co-payment on hospital meals remain unchanged.

Patients in South Korea with rare and severe intractable diseases who are registered under the National Health Insurance special co-payment program are set to pay 7% of covered medical costs instead of 10% for care received from December 1, 2026. The Ministry of Health and Welfare, which runs Korea's health and social security policy, published a draft amendment to the Enforcement Decree of the National Health Insurance Act on November 4 and expects average annual out-of-pocket spending per patient to fall from about KRW 750,000 to about KRW 530,000. Public comments close on November 16. Whether foreign residents enrolled in Korean health insurance qualify should be confirmed with the National Health Insurance Service, the public insurer that administers the program.
Korean hospital receipts list separately the share of covered (insured) treatment costs that the patient pays. For people in long-term treatment, even a small change in that rate adds up over a year. The benefit, however, applies only to covered treatment for patients registered under the special co-payment program, known in Korea as sanjeong teukrye. Knowing one's registration status and the split between covered and non-covered services matters more than the headline figure.
Korea's rare disease co-payment falls from 10% to 7% of covered costs
What changes is the share of covered health insurance costs that patients pay themselves. Ministry of Health and Welfare Notice No. 2026-827, posted on the National Participatory Legislation Center, the government portal where draft laws are opened for comment, lowers the co-payment rate for patients with rare and severe intractable diseases from 10/100 to 7/100.
People who already receive reduced co-payments, such as low-income households, will also pay the same 7% when treated for a rare or severe intractable disease. The ministry cited the medical cost burden on patients and families facing long-term treatment for conditions that are difficult to cure.
| Item (% / KRW) | Current | From December 1, 2026 | First half of 2028 (planned) |
|---|---|---|---|
| Co-payment rate on covered costs | 10% | 7% | 5% |
| Average annual out-of-pocket cost per patient (estimate) | About KRW 750,000 | About KRW 530,000 | Not announced |
| Non-covered costs · 50% on hospital meals | Applied | Unchanged | Not announced |
The table reflects the Ministry of Health and Welfare announcement of November 4, 2026. The average annual out-of-pocket figures are ministry estimates, and the 5% rate is a planned cut for the first half of 2028.
Who qualifies: 1.36 million registered patients
The cut covers about 1.36 million patients with rare and severe intractable diseases who are registered under the special co-payment program. The program lowers co-payments for conditions with high treatment costs and applies only to registered patients. According to Dailypharm, it covers 1,389 rare diseases and 234 severe intractable diseases.
Newsis reported that the cut is the first step in carrying out the first-phase plan to strengthen health insurance coverage, approved on September 8 at the 15th meeting of the Health Insurance Policy Deliberation Committee, the body that sets benefit and fee policy. According to the same report, the plan as a whole is expected to provide up to KRW 800 billion a year in support to 1.97 million people.
The two figures refer to different groups. The 1.36 million are those eligible for the lower co-payment, while the 1.97 million are the beneficiaries of the full plan, which also includes support for diabetes devices and dental implants. Keeping the two apart makes it easier for readers to estimate what applies to them.
Yoo Joo-heon, director-general for health insurance policy at the Ministry of Health and Welfare, said on November 4 that the amendment is "a first step toward lowering the out-of-pocket burden for patients with rare and severe intractable diseases to the level of other severe illnesses."

Comments close November 16; the change is planned for December 1
The amendment is not yet final. The ministry said it will collect comments during the public notice period, then seek review by the Ministry of Government Legislation, which vets draft regulations, and approval by the Cabinet ahead of the planned start on December 1.
| Date | Stage | Details |
|---|---|---|
| September 8, 2026 | Approved by the Health Insurance Policy Deliberation Committee | First-phase plan to strengthen health insurance coverage |
| November 4 | Public notice of draft | Draft partial amendment to the Enforcement Decree published |
| November 16 | Comment deadline | National Participatory Legislation Center · ministry's Insurance Policy Division |
| After comments close | Ministry of Government Legislation review · Cabinet approval | Date not announced |
| December 1 (planned) | Takes effect | 7% for care received from that date |
| First half of 2028 (planned) | Second-phase cut | Co-payment rate of 5% |
The table is based on the Ministry of Health and Welfare announcement and the public notice of November 4, 2026. Any organization or individual may submit comments until November 16, either online through the National Participatory Legislation Center or by sending a written opinion to the ministry's Insurance Policy Division.
What changes on the receipt, and what stays the same
The 7% rate applies to the patient's share of covered treatment costs. Non-covered treatment costs and the 50% co-payment on hospital meals stay as they are. For patients whose treatment relies heavily on non-covered services, the actual saving may be smaller than the announced average.
First, patients should confirm whether they are registered under the special co-payment program. The billing office of the treating hospital or the National Health Insurance Service can check this.
Second, setting a December receipt next to a November one and comparing the co-payment rate on covered costs shows whether the cut has been applied.
Other changes arriving with the co-payment cut
The same plan carries other timelines. According to Dailypharm, about 11,000 patients with severe type 2 diabetes will receive new support for device costs from December. From January 2027, people aged 65 and over who have lost all their teeth will be covered for two implants.
The time it takes for rare disease treatments to be listed for health insurance coverage, previously 240 days, is to be cut to no more than 100 days. Re-registration criteria for the special co-payment program were revised in September for 95 conditions, including Guillain-Barré syndrome, and will be extended to 312 conditions by next year.
The cut affects only covered treatment costs for registered patients. Patients and families with treatment scheduled for December should first check their registration status and how their receipts split covered and non-covered items.
Frequently asked questions
When does Korea's 7% rare disease co-payment take effect?
The Ministry of Health and Welfare plans to apply it to care received on or after December 1, 2026. It becomes final only after the public notice period ends and the amendment passes review by the Ministry of Government Legislation and Cabinet approval.
Does the 7% rate also apply to non-covered treatment?
No. The cut applies only to treatment covered by national health insurance. Non-covered treatment costs and the 50% co-payment on hospital meals stay the same.
How can I comment on the draft decree amendment?
Comments can be submitted online through the National Participatory Legislation Center or sent in writing to the Ministry of Health and Welfare's Insurance Policy Division until November 16, 2026. Both organizations and individuals may take part.
Sources
- Ministry of Health and Welfare (Korea.kr policy briefing), Health insurance co-payment for rare and severe intractable diseases cut from 10% to 7% (Nov 4, 2026) — korea.kr
- National Participatory Legislation Center, Public notice of draft partial amendment to the Enforcement Decree of the National Health Insurance Act (Ministry of Health and Welfare Notice No. 2026-827, Nov 4, 2026) — opinion.lawmaking.go.kr
- Newsis, Co-payment for 1.36 million patients with severe and rare diseases to fall from 10% to 7% (Sep 8, 2026) — newsis.com
- Dailypharm, Rare and intractable disease co-payment to be cut in stages to 5%: "KRW 800 billion a year" (Sep 8, 2026) — m.dailypharm.com




